Neuropathy Clinical Trials

21 recruiting

Neuropathy Trials at a Glance

214 actively recruiting trials for neuropathy are listed on ClinicalTrialsFinder across 6 cities in 58 countries. The largest study group is Not Applicable with 83 trials, with the heaviest enrollment activity in Houston, Boston, and Paris. Lead sponsors running neuropathy studies include Riphah International University, argenx, and M.D. Anderson Cancer Center.

Browse neuropathy trials by phase

Treatments under study

About Neuropathy Clinical Trials

Looking for clinical trials for Neuropathy? There are currently 21 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Neuropathy trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Neuropathy clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 214 trials

Recruiting
Phase 2

Zanubritnib and Anti-MAG Neuropathy

Anti-MAG IgM-associated Demyelinating Polyneuropathy
Azienda Ospedaliera di Padova50 enrolled1 locationNCT07392229
Recruiting
Not Applicable

Closed Loop Spinal Cord Stimulation for Chemotherapy Induced Peripheral Neuropathy, a Pilot Study.

Peripheral Neuropathy Due to Chemotherapy
M.D. Anderson Cancer Center10 enrolled1 locationNCT06616649
Recruiting
Phase 4

Effect of GLP-1RA on Cardiac Autonomic Neuropathy in Type 2 Diabetes

Type 2 DiabetesDiabetes With Diabetic Autonomic Neuropathy (Diagnosis)
The First Affiliated Hospital with Nanjing Medical University60 enrolled1 locationNCT07558863
Recruiting
Not Applicable

The Treatment of Painful Diabetic Neuropathy With Diet

Peripheral Neuropathy With Type 2 DiabetesPainful Diabetic Neuropathy (PDN)Vegan Diet
AdventHealth40 enrolled1 locationNCT07509671
Recruiting
Phase 3

Study on the Efficacy and Safety of Mecobalamin in Preventing Taxane-related Peripheral Neuropathy

Peripheral Neuropathy Due to ChemotherapyPeripheral Neuropathy, Chemotherapy-induced
Qinghai Red Cross Hospital326 enrolled4 locationsNCT07423390
Recruiting

Patisiran-Lipid Nanoparticle (LNP) Pregnancy Surveillance Program

PolyneuropathyHereditary Transthyretin-mediated (hATTR) Amyloidosis
Alnylam Pharmaceuticals10 enrolled7 locationsNCT05040373
Recruiting

Real-World Efgartigimod Effectiveness in CIDP: A Prospective Study

Chronic Inflammatory Demyelinating PolyradiculoneuropathyCIDPCIDP (Chronic Inflammatory Demyelinating Polyradiculoneuropathy)
argenx200 enrolled23 locationsNCT07264426
Recruiting
Not Applicable

Vibratory Anesthesia on Pain Following Corticosteroid Injections

ArthropathyBilateral Arthritis of WristCompression Neuropathy+2 more
The University of Texas Medical Branch, Galveston165 enrolled1 locationNCT07553273
Recruiting
Phase 2

A Randomized Controlled Trial on the Efficacy and Safety of Umbilical Cord Mesenchymal Stem Cell Therapy in Subjects With Moderate to Severe Diabetic Peripheral Neuropathy

Diabetic Peripheral Neuropathy (DPN)
Min Long140 enrolled1 locationNCT07183761
Recruiting

Investigational Use of Neuromuscular Ultrasound

Peripheral NeuropathyNormal PhysiologyMuscular Dystrophy+1 more
National Institute of Neurological Disorders and Stroke (NINDS)150 enrolled1 locationNCT05237973
Recruiting
Phase 2

IMVT-1402 in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Chronic Inflammatory Demyelinating Polyneuropathy
Immunovant Sciences GmbH162 enrolled135 locationsNCT07032662
Recruiting
Phase 2

A Study of TAK-411 in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Takeda36 enrolled20 locationsNCT06798012
Recruiting
Phase 3

A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Chronic Inflammatory Demyelinating Polyneuropathy
Sanofi160 enrolled115 locationsNCT06290141
Recruiting
Not Applicable

Nerve Excitability in Cisplatin-Induced Peripheral Neuropathy

NeuropathyPeripheral NeuropathyPeripheral Neuropathy Due to Chemotherapy+1 more
Ka-Wai Ho60 enrolled2 locationsNCT07095998
Recruiting
Phase 1

Intraneural Administration of scAAV9/JeT-GAN Into the Vagus Nerve for Patients With Giant Axonal Neuropathy (GAN)

Giant Axonal Neuropathy (GAN)
University of Texas Southwestern Medical Center4 enrolled1 locationNCT07543991
Recruiting
Phase 3

A Study to Evaluate the Pharmacokinetics and Safety of XEMBIFY Versus Gamunex-C in Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy

CIDP (Chronic Inflammatory Demyelinating Polyradiculoneuropathy)
Grifols Therapeutics LLC40 enrolled2 locationsNCT07540221
Recruiting
Phase 3

A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP

Chronic Inflammatory Demyelinating PolyneuropathyCIDPCIDP - Chronic Inflammatory Demyelinating Polyneuropathy
argenx218 enrolled47 locationsNCT06920004
Recruiting
Phase 3

A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)

Chronic Inflammatory Demyelinating Polyneuropathy
Dianthus Therapeutics256 enrolled158 locationsNCT06858579
Recruiting
Phase 3

TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy

Hereditary Transthyretin-Mediated Amyloidosis With PolyneuropathyhATTR-PN
Alnylam Pharmaceuticals125 enrolled4 locationsNCT07223203
Recruiting
Phase 1

A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refractory Autoimmune Neurologic Diseases

Myasthenia GravisMultiple SclerosisChronic Inflammatory Demyelinating Polyneuropathy
Kite, A Gilead Company52 enrolled3 locationsNCT07304154